FDA Needs Stronger Postmarket Reporting Process For Approved Drugs – Poll
This article was originally published in The Tan Sheet
Executive Summary
Approximately 70% of Americans favor bolstering FDA's postmarketing review of drugs and medical devices that are linked to adverse events, according to a recent poll
You may also be interested in...
Increased Authority, Funding Needed To “Fix The FDA,” Coalition Says
An ad campaign targeting inside-the-Beltway audiences seeks to pressure Congress for increased FDA funding
Increased Authority, Funding Needed To “Fix The FDA,” Coalition Says
An ad campaign targeting inside-the-Beltway audiences seeks to pressure Congress for increased FDA funding
Increased Authority, Funding Needed To “Fix The FDA,” Coalition Says
An ad campaign targeting inside-the-Beltway audiences seeks to pressure Congress for increased FDA funding